Paradigm Medical Industries, Inc.
PDMI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -159,381,767.60% | -2,603,953.47% | -103,776.06% | -3,402,391.53% |
| EV / EBITDA | -6.65 | -3.04 | -4.43 | -3.43 |
| Quality | ||||
| ROIC | -137.91% | -531.82% | -525.49% | 1,430.09% |
| Gross Margin | 68.01% | 57.16% | 52.45% | 44.08% |
| Cash Conversion Ratio | 1.56 | 1.25 | 0.50 | 0.29 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.46% | -16.77% | -22.90% | -16.91% |
| Free Cash Flow Growth | 38.79% | -142.77% | 1.19% | 55.59% |
| Safety | ||||
| Net Debt / EBITDA | -6.65 | -3.04 | -4.43 | -3.43 |
| Interest Coverage | 2.23 | 5.38 | 2.05 | 1.36 |
| Efficiency | ||||
| Inventory Turnover | 0.56 | 0.61 | 0.81 | 1.07 |
| Cash Conversion Cycle | 96.76 | 203.53 | -180.34 | 161.63 |